Selective bet inhibitors and uses thereof
AssigneeTay Therapeutics Limited
InventorsChristopher Andrew WOODLAND, Mark BELL, Iain STUART
Life of this patent
Estimating the term…
Loading patent…
AssigneeTay Therapeutics Limited
InventorsChristopher Andrew WOODLAND, Mark BELL, Iain STUART
Estimating the term…
This disclosure relates to certain pyrrolopyridone compounds. Certain compounds of the disclosure are potent and selective Bromodomain and Extra-Terminal (BET) inhibitors. The disclosure also relates to pharmaceutically acceptable salts of the compounds or N-oxides thereof, methods of treating diseases and disorders using the compounds, salts, or N-oxides thereof and compositions comprising the compounds salts or N-oxides thereof. The disclosure additionally relates to methods for the treatment of inflammatory and autoimmune diseases and disorders (e.g., skin diseases and disorders, joint and joint-related diseases and disorders, and fibrosis or fibrosis-associated diseases or disorders) using potent and selective BET inhibitors and formulations comprising the disclosed BET inhibitors.
A compound of formula (XI), or a pharmaceutically acceptable salt or N-oxide thereof:
Dependencies are inferred from the claim text.